Abraxis Biosciences, Inc. 4
4 · Abraxis Biosciences, Inc. · Filed Dec 3, 2007
Insider Transaction Report
Form 4
NIMER STEPHEN
Director
Transactions
- Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+2,970→ 2,970 totalExercise: $94.84From: 2007-11-29Exp: 2015-07-21→ Common Stock (2,970 underlying) - Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+1,272→ 1,272 totalExercise: $82.94From: 2007-11-29Exp: 2014-12-13→ Common Stock (1,272 underlying) - Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+4,773→ 4,773 totalExercise: $25.15From: 2007-11-29Exp: 2011-12-14→ Common Stock (4,773 underlying) - Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+1,909→ 1,909 totalExercise: $29.44From: 2007-11-29Exp: 2012-10-25→ Common Stock (1,909 underlying) - Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+4,243→ 4,243 totalExercise: $47.30From: 2007-11-29Exp: 2016-08-01→ Common Stock (4,243 underlying) - Award
Nonqualified Stock Option (Right to Purchase)
2007-11-28+10,000→ 10,000 totalExercise: $55.44From: 2008-11-29Exp: 2017-11-29→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The Option was issued in connection with the spin-off of issuer's common stock from APP Pharmaceuticals, Inc. (formerly Abraxis BioScience, or "New APP") on November 13, 2007 in exchange for existing New APP options. Under the terms of the employee matters agreement executed between the issuer and New APP, the number of shares and exercise price became calculable on November 28, 2007.
- [F2]The exercise price of this option was determined on the first ten days trading average of the issuer's common stock, which was determinable on November 28, 2007.